Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 25, 2023

SELL
$0.35 - $0.82 $6,140 - $14,386
-17,544 Reduced 18.61%
76,741 $36,000
Q1 2023

May 12, 2023

SELL
$0.46 - $1.2 $3,801 - $9,918
-8,265 Reduced 8.06%
94,285 $43,000
Q4 2022

Jan 09, 2023

SELL
$0.85 - $1.49 $38,462 - $67,422
-45,250 Reduced 30.62%
102,550 $92,000
Q2 2022

Aug 16, 2022

BUY
$2.66 - $5.81 $393,148 - $858,718
147,800 New
147,800 $393,000

Others Institutions Holding LMDX

About LumiraDx Ltd


  • Ticker LMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 170,688,000
  • Market Cap $1.71M
  • Description
  • LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The compa...
More about LMDX
Track This Portfolio

Track Cambridge Trust CO Portfolio

Follow Cambridge Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Trust CO with notifications on news.